Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine Hydrochloride in Familial Adenomatous Polyposis
NCT03333265Phase 3Completed
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Sep 2017
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of berberine in familial adenomatous polyposis (FAP), sponsored by Xijing Hospital of Digestive Diseases. Started Sep 2017; status: completed.
02
Drugs
berberine
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT03333265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03333265.